Advancing in vitro and (PATHO)physiology-based pharmacokinetics models to understand and predict pulmonary absorption and tissue retention of inhaled drugs

Ended Definitive Contract Awarded Last action

Contract number
75F40122C00182
Awardee
Awarding agency
Obligated
$1,844,289

Award facts

Contract value 100% obligated
$1,844,289.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost No Fee
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · No cost modification to change the period of performance end date to september 29, 2026. $0
Vendor DUNS or Name Change - Non-Novation P00001 · The purpose of this modification is to update the vendor UEI from LFZGKJMDW747 to NNFQH1JAPEP3. $0
Original award $1,844,289

About this award

This is a $1,844,289.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research. The contract is for advancing in vitro and (patho)physiology-based pharmacokinetics models to understand and predict pulmonary absorption and tissue retention of inhaled drugs. The contract has no set-aside designation.

As a subcontractor, Simulations Plus Inc. will provide modeling and simulation services to support the project. Simulations Plus specializes in developing pharmaceutical modeling and simulation software used by federal agencies for drug discovery, development, and regulatory assessment. This contract leverages UF's expertise in biomedical research and Simulations Plus' capabilities in PBPK modeling to enhance the prediction of drug behavior in the human body, which can streamline the drug development process and improve regulatory submissions.

Subawards

Subcontractor Amount Awarded
Simulations Plus Inc. THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE VENDOR UEI FROM LFZGKJMDW747 TO NNFQH1JAPEP3. Mr. Mullin will serve as consortium PI. He will coordinate the… $337,649

Quick answers

Who was awarded contract 75F40122C00182?

75F40122C00182 was awarded to University Of Florida by Food and Drug Administration (Department of Health and Human Services) on September 21, 2022.

How much is contract 75F40122C00182 worth?

The government has obligated $1,844,289 on 75F40122C00182.

Was contract 75F40122C00182 competed?

The extent of competition for 75F40122C00182 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award